HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The influence of changing dose rate patterns from inhaled beta-gamma emitting radionuclide on lung cancer.

AbstractPURPOSE:
Dose and dose rate are both appropriate for estimating risk from internally deposited radioactive materials. We investigated the role of dose rate on lung cancer induction in Beagle dogs following a single inhalation of strontium-90 (90Sr), cerium-144 (144Ce), yttrium-91 (91Y), or yttrium-90 (90Y). As retention of the radionuclide is dependent on biological clearance and physical half-life a representative quantity to describe this complex changing dose rate is needed.
MATERIALS AND METHODS:
Data were obtained from Beagle dog experiments from the Inhalation Toxicology Research Institute. The authors selected the dose rate at the effective half-life of each radionuclide (DRef).
RESULTS:
Dogs exposed to DRef (1-100 Gy/day) died within the first year after exposure from acute lung disease. Dogs exposed at lower DRef (0.1-10 Gy/day) died of lung cancer. As DRef decreased further (<0.1 Gy/day 90Sr, <0.5 Gy/day 144Ce, <0.9 Gy/day 91Y, <8 Gy/day 90Y), survival and lung cancer frequency were not significantly different from control dogs.
CONCLUSION:
Radiation exposures resulting from inhalation of beta-gamma emitting radionuclides that decay at different rates based on their effective half-life, leading to different rates of decrease in dose rate and cumulative dose, is less effective in causing cancer than acute low linear energy transfer exposures of the lung.
AuthorsStephanie Puukila, Christopher Thome, Antone L Brooks, Gayle Woloschak, Douglas R Boreham
JournalInternational journal of radiation biology (Int J Radiat Biol) Vol. 94 Issue 11 Pg. 955-966 (11 2018) ISSN: 1362-3095 [Electronic] England
PMID30257126 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Administration, Inhalation
  • Animals
  • Beta Particles (adverse effects)
  • Dogs
  • Gamma Rays (adverse effects)
  • Half-Life
  • Lung Neoplasms (etiology)
  • Neoplasms, Radiation-Induced (etiology)
  • Radiation Dosage
  • Risk Assessment

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: